CME From JCPSleep experts Drs Roth and Winkelman explore the differential diagnosis and treatment of narcolepsy in this CME journal activity. [top]

Recognizing and Treating Excessive Daytime Sleepiness in Patients With Narcolepsy

Recognizing and Treating Excessive Daytime Sleepiness in Patients With Narcolepsy

Thomas Roth, PhD, and John W. Winkelman, MD, PhD

[Activity] [Posttest] 11/30/2022

JCP CME Activities

Effect of Scheduling a Post-Discharge Outpatient Mental Health Appointment on the Likelihood of Successful Transition From Hospital to Community-Based Care

Thomas E. Smith

[Activity] [Posttest] 10/31/2022

Omega-3 Fatty Acid Supplementation for Perinatal Depression: A Meta-Analysis

Roel J. T. Mocking, Katja Steijn, Carolien Roos, Johanna Assies, Veerle Bergink, Henricus G. Ruhé, Aart H. Schene

[Activity] [Posttest] 10/31/2022

Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review

Michelle J. Blumberg, Sophie R. Vaccarino, Shane J. McInerney

[Activity] [Posttest] 8/31/2022

Characterization of the Quality of Electroconvulsive Therapy Among Older Medicare Beneficiaries

Taeho Greg Rhee; Mark Olfson; Kyaw Sint; Samuel T. Wilkinson

[Activity] [Posttest] 8/31/2022

Efficacy, effect on mood symptoms, and safety of deep brain stimulation in refractory obsessive-compulsive disorder: a systematic review and meta-analysis

Filipe Peste Martinho, Gonçalo Silva Duarte, Frederico Simões do Couto

[Activity] [Posttest] 5/31/2022

Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie

Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, Stephen R. Marder, Leslie Citrome, John W. Newcomer, Delbert G. Robinson, Donald C. Goff, Deanna L. Kelly, Oliver Freudenreich, Daria Piacentino, Michael Paulzen, Andreas Conca, Gerald Zernig, Ekkehard Haen, Pierre Baumann, Christoph Hiemke, Gerhard Gründer, for the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrier

[Activity] [Posttest] 6/30/2022

New-Onset Delusions Heralding an Underlying Neurodegenerative Condition: A Case Report and Review of the Literature

Emily A. Ferenczi; Michael G. Erkkinen; Mel B. Feany; Barry S. Fogel; Kirk R. Daffner

[Activity] [Posttest] 4/30/2022

Disordered Aggression and Violence in the United States

Emil F. Coccaro, and Royce J. Lee

[Activity] [Posttest] 4/30/2022

The Value of Neuropsychological Assessment in the Differentiation Between Behavioral Variant Frontotemporal Dementia and Late-Onset Psychiatric Disorders

Jozefien M. Overbeek, Nicole Korten, Flora Gossink, Jay Fieldhouse, Marleen van de Beek, Lianne Reus, Annemieke Dols, Yolande Pijnenburg, and Sigfried Schouws

[Activity] [Posttest] 2/28/2022

Past Psychiatric Conditions as Risk Factors for Postpartum Depression: A Nationwide Cohort Study

Sara L. Johansen, Ben A. Stenhaug, Thalia K. Robakis, Katherine E. Williams, and Mark R. Cullen

[Activity] [Posttest] 1/31/2022

Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History

Erica L. F. Buchalter, Hanadi Ajam Oughli, Eric J. Lenze, David Dixon, J. Philip Millera, Daniel M. Blumberger, Jordan F. Karp, Charles F. Reynolds III, and Benoit H. Mulsant

[Activity] [Posttest] 12/31/2021

Prescription Opioid Misuse in US Older Adults: Associated Comorbidities and Reduced Quality of Life in the National Epidemiologic Survey of Alcohol and Related Conditions-III

Ty S. Schepis, and Sean Esteban McCabe

[Activity] [Posttest] 11/30/2021

Real-World Outcomes in the Management of Refractory Psychosis

Amir Krivoy, Dan Joyce, Derek Tracy, Fiona Gaughran, James MacCabe, John Lally, Whiskey Eromona, S. Neil Sarkar, and Sukhwinder S. Shergill

[Activity] [Posttest] 10/31/2021

Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis

Sally Mustafa, Ridha Joober, Srividya Iyer, Jai Shah, Martin Lepage, and Ashok Malla

[Activity] [Posttest] 9/30/2021

High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder

Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A. Axelson; Daniel P. Dickstein, MD; Tina R. Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D. Ryan; Michael A. Strober; Martin B. Keller; and Benjamin I. Goldstein

[Activity] [Posttest] 8/31/2021

Benzodiazepine Use During Pregnancy Alone or in Combination With an Antidepressant and Congenital Malformations: Systematic Review and Meta-Analysis

Sophie Grigoriadis; Lisa Graves; Miki Peer; Lana Mamisashvili; Cindy-Lee Dennis; Simone N. Vigod; Meir Steiner; Cara Brown; Amy Cheung; Hiltrud Dawson; Neil Rector; Melanie Guenette; and Margaret Richter

[Activity] [Posttest] 8/30/2021

Treatment of Common Mental Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III

Mark Olfson, Carlos Blanco, Melanie M. Wall, Shang-Min Liu, and Bridget F. Grant

[Activity] [Posttest] 6/30/2021

Sex and Pubertal Status Moderate the Association Between ADHD and Depression Symptoms: An Examination from Preadolescence Through Late Adolescence

Dara E. Babinski, Daniel A. Waschbusch, and James G. Waxmonsky

[Activity] [Posttest] 6/30/2022

Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence

Roger D. Weiss, Margaret L. Griffin, David E. Marcovitz, Blake T. Hilton, Garrett M. Fitzmaurice, R. Kathryn McHugh, and Kathleen M. Carroll

[Activity] [Posttest] 4/30/2021

Sexually Transmitted Infection Among Adolescents and Young Adults With Bipolar Disorder: A Nationwide Longitudinal Study

Mu-Hong Chen, Han-Ting Wei, Ya-Mei Bai, Kai-Lin Huang, Nai-Ying Ko, Tung-Ping Su, Cheng-Ta Li, Wei-Chen Lin, Shih-Jen Tsai, Tzeng-Ji Chen, and Ju-Wei Hsu

[Activity] [Posttest] 3/31/2021

Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

Eric T. Dobson, Michael H. Bloch, and Jeffrey R. Strawn

[Activity] [Posttest] 2/28/2021

Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort

David Misdrahi, Arnaud Tessier, Antoine Daubigney, Wassilios G. Meissner, Franck Schurhoff, Laurent Boyer, Ophélia Godin, Ewa Bulzacka, Bruno Aouizerate, Meja Andrianarisoa, Fabrice Berna, Delphine Capdevielle, Isabelle Chereau-Boudet, Thierry D’Amato, Caroline Dubertret, Julien Dubreucq, Catherine Faget-Agius, Christophe Lançon, Jasmina Mallet, Christine Passerieux, Romain Rey, Aurélie Schandrin, Mathieu Urbach, Pierre Vidailhet, Pierre-Michel Llorca, and Guillaume Fond for the FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group

[Activity] [Posttest] 2/28/2021

Blood Lithium Monitoring Practices in a Population-Based Sample of Older Adults

Soham Rej, Nathan Herrmann, Andrea Gruneir, Racquel Jandoc, Eric McArthur, Stephanie Dixon, and Amit X. Garg

[Activity] [Posttest] 12/31/2020

The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery

Using Long-Acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia

Christoph U. Correll, MD, and John Lauriello, MD

[Activity] [Posttest] 8/31/2022

Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

Leslie Citrome, MD, MPH, and Stephen R. Saklad, PharmD, BCPP

[Activity] [Posttest] 4/30/2022

Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia

Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia

Joseph P. McEvoy, MD, and Daniel E. Kremens, MD, JD

[Activity] [Posttest] 2/28/2022

A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease

Current and Emerging Solutions to Challenges in the Management of Alzheimer’s Disease

Alireza Atri, MD, PhD; Danielle Goldfarb, MD; Simon Sheard, DO; and Lynn Shaughnessy, PsyD

[Activity] [Posttest] 12/31/2021

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

John M. Kane, MD, and Christoph U. Correll, MD

[Activity] [Posttest] 10/31/2021

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care

John Lauriello, MD, and Diana O. Perkins, MD

[Activity] [Posttest] 2/28/2021

CME From PCCWhat is the difference between errors and discrepancies in radiological interpretations? How often do errors occur, and how can they be avoided? Explore these questions in this CME activity from Banner Alzheimer’s Institute. [top]

PCC CME Activities

Spotting the Zebra: Keeping an Open Mind When Evaluating Cognitive Impairment

Ganesh Gopalakrishna, MD, and Kyle Angus Hendrie, DO

[Activity] [Posttest] 10/31/2022

Who Has the Ability to Consent?

La Vonne Ann Downey and Les Zun

[Activity] [Posttest] 8/31/2022

Psychiatric Prodrome in Anti-NMDAR–Associated Encephalopathy: Clinical and Pathophysiologic Considerations

Anh-Vu Nguyen, Keith A. Young, James A. Bourgeois

[Activity] [Posttest] 7/31/2022

Organic Psychosis Causing Secondary Schizophrenia in One-Fourth of a Cohort of 200 Patients Previously Diagnosed With Primary Schizophrenia

João Gama Marques

[Activity] [Posttest] 4/30/2022

Glucagon-Like Peptide Analogs Are Superior for Diabetes and Weight Control in Patients on Antipsychotic Medications: A Retrospective Cohort Study

Lauren T. Perlis, J. Steven Lamberti, and Susanne U. Miedlich

[Activity] [Posttest] 2/28/2022

Hypertensive Urgency and Emergency in Alcohol Withdrawal: A Literature Review

Ermal Bojdani, Anderson Chen, Tina Zhang, Nida Naqvi, Dil Tahera

[Activity] [Posttest] 12/31/2021

No MMSE for You! A Case of an “Uncooperative” Patient With Early-Onset Dementia

Po-Heng Tsai, Gurmehr Kaur, Ganesh Gopalakrishna

[Activity] [Posttest] 10/31/2021

Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—HDC/DFMC Bridge Project, Phase 1: Group Concept Mapping

Keri Hager; Margarette Kading; Carolyn O’Donnell; Ann Yapel; Danielle MacDonald; Jennifer Nelson Albee; Cynthia Nash; Colleen Renier; Katherine Dean; and Mark Schneiderhan

[Activity] [Posttest] 8/31/2021

Lithium Neurotoxicity Due to Second-Generation Antipsychotics Combined With Lithium: A Systematic Review

Ivan Netto, Vivek H. Phutane, and Bipin Ravindran

[Activity] [Posttest] 6/30/2022

Posttraumatic Stress Disorder Symptoms, Functioning, and Suicidal Ideation in US Military Veterans: A Symptomics Approach

Lorig K. Kachadourian, Ilan Harpaz-Rotem, Jack Tsai, Steven M. Southwick, and Robert H. Pietrzak

[Activity] [Posttest] 4/30/2021

Psychotropic Medication Monitoring: A Review

Matthew A. Schreiber, Stephanie C. Armstrong, and Jesse D. Markman

[Activity] [Posttest] 2/28/2021

Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder

Mohan Gautam and Deepak Prabhakar

[Activity] [Posttest] 12/31/2020